THE API POWDER DIARIES

“The current problem has exposed some structural weaknesses inside the EU’s medicines provide chain and a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that offer chain difficulties be dealt with within an EU pharmaceutical strategy anticipated for being introdu